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Clearance of apoptotic cells by phagocytic cells plays a significant role in the resolution of inflammation, protecting tissue from harmful
exposure to the inflammatory and immunogenic contents of dying cells. Apoptosis induces cell surface changes that are important for
recognition and engulfment of cells by phagocytes. These changes include alterations in surface sugars, externalization of phosphatidylserine
and qualitative changes in the adhesion molecule ICAM-3. Several studies have contributed to clarify the role of the receptors on the surface
of phagocytes that are involved in apoptotic cell clearance. The phagocytic removal of apoptotic cells does not elicit pro-inflammatory
responses; in contrast, apoptotic cell engulfment appears to activate signals that suppress release of pro-inflammatory cytokines. Therefore,
clearance of apoptotic leucocytes is implicated in the resolution of inflammation and mounting evidence suggests that defective clearance of
apoptotic cells contributes to inflammatory and autoimmune diseases. Defining the ligands on apoptotic cells and the corresponding receptors
on phagocytes with which they engage, is likely to lead to the development of novel anti-inflammatory pro-resolution drugs. In this article,
we will review the recognition and signaling mechanisms involved in the phagocytosis of apoptotic cells as well as the role of endogenous
compounds that play a relevant role in the modulation of inflammation. We will also discuss what is currently known about diseases that may
reflect impaired phagocytosis and the consequences on inflammation and immune responses.
D 2003 Elsevier B.V. All rights reserved.Keywords: Apoptotic cell; Phagocytosis; Resolution of inflammation1. Introduction
Phagocytosis is a phylogenetically ancient process that is
an essential feature of the immune response. It was first
observed by Elie Metchnikoff [1], a Russian biologist who
in the late 19th century observed that ‘microphages’ were
englobed by macrophages. Since the recognition by Metch-
nikoff of the biological importance of phagocytosis, inves-
tigators have strived to unravel the molecular basis of this
process. Today phagocytosis is defined as the cellular
engulfment of large particles (>0.5 Am).
Apoptosis, or programmed cell death, is a critical
process in natural tissue homeostasis and results in imme-
diate removal of the dying cell. As cells undergo apoptosis,
they are rapidly phagocytosed by professional phagocytes,0925-4439/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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or by semi-professional phagocytes in the surrounding
tissue such as mesangial cells [5,6]. In this way, despite
the high turnover of cells on a daily basis, tissues are
protected from harmful exposure to the inflammatory or
immunogenic contents of dying cells by phagocytic clear-
ance. Should cells die by necrosis and disintegrate in situ,
release of their contents may exacerbate the local inflam-
matory response and trigger further leukocyte influx.
Therefore, phagocytic removal of apoptotic leukocytes is
a prerequisite to restore normal tissue function and plays a
critical role in the resolution of inflammation [2–4,7,8]. In
addition to removing cells before they undergo lysis, it is
proposed that ingestion of apoptotic cells results in potent
anti-inflammatory and immunosuppressive effects through
the production of anti-inflammatory cytokines such as
TGF-h1 and PGE2 and the suppression of release of pro-
inflammatory mediators, including IL-8, TNF-a and TXA2,
from activated Mf. This proposal is based on in vitro
studies [9,10]. More recently, in vivo models of inflamma-
tion have been utilized to demonstrate that clearance of
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late-stimulated peritonea and endotoxin-stimulated lungs
leads to accelerated resolution of inflammation, mediated
by the increased production of TGF-h1 [11]. In addition,
apoptotic cell instillation in endotoxin-stimulated lungs
reduced pro-inflammatory chemokine levels in the bron-
choalveolar lavage fluid [11].
The initial event in phagocytosis is the recognition of
the target. Successful engulfment requires that apoptotic
cells expose an ‘‘eat me signal’’ on their cell surface [3].
The phagocyte recognizes this signal and transduces it to
the cell machinery required for engulfment. Recognition of
apoptotic cells by phagocytes depends on rearrangement of
the lipid portion of the plasma membrane on the target
cells. Apoptosis leads to disruption of the normal asym-
metric distribution of phospholipid across the plasma
membrane that generates ligands on the cell surface [12],
facilitating recognition by specific receptors on the phag-
ocytes. Phagocytes show significant redundancy in recog-
nition strategies and are able to use many receptors at the
same time [2,4]. Subsequent to recognition mediated
through tethering, specific cellular responses culminating
in the transduction of a phagocytic signal are generated [4].
These signals target the submembranous cytoskeleton fa-
cilitating changes that lead to engulfment, followed by the
process of internalization [13]. Finally, the ingested particle
enters the lysosomal system in the phagocyte where it is
degraded.
In this article, we will review the recognition and
signaling mechanisms involved in phagocytosis of apoptotic
cells as well as the role of endogenous compounds that play
a role in the modulation of inflammation. We will also
discuss the potential of impaired phagocytosis in the path-
ogenesis of inflammation and immune disorders.2. Recognition of the target by the phagocyte
2.1. Exposure of phosphatidylserine
Amongst the multiple changes on the surface of the
apoptotic cells that facilitate their recognition, the best-
characterized is the loss of phospholipid asymmetry and
subsequent exposure of phosphatidylserine (PS) [14–17]. In
viable cells, maintenance of the phospholipid asymmetry is
attributed largely to an activity of the aminophospholipid
translocase [18]. In the early stages of apoptosis, an inhibi-
tion of this translocase, in part due to an elevation in
intracellular Ca2 + and activation of a lipid scramblase,
allows the appearance of PS on the surface of the cells
[19]. The exposure of PS is facilitated also by the ATP-
binding cassette 1 (ABC1) transporter, that plays a role in
both phagocytic cells and target cells for efficient engulf-
ment [20–22]. Deletion of the transporter gene or down-
regulation of its products reduce exposure of PS during
cellular activation and apoptosis [20,21].PS on apoptotic cells is recognized by a phagocyte PS
receptor [16]. The PS receptor is conserved across evolu-
tion and, differently from the other molecules involved in
phagocytosis, possesses stereospecificity of interaction
with PS. However, there are a number of PS-binding
proteins that can act as a bridge between apoptotic cells
and phagocytes such as plasma-protein h2-glycoprotein I,
the product of growth arrest-specific gene 6 (Gas6) that
binds to the Mer kinase and the protein milk-fat globule
epidermal growth factor 8 that bridge with vitronectin
receptor integrin (avh3) [23–25] and protein S that binds
PS [26]. Interestingly data from apoptotic lymphocytes
indicate that oxidative stress inhibits phagocytosis of
apoptotic cells that have externalized PS, suggesting that
PS exposure is necessary but not sufficient to target
apoptotic cells for phagocytosis [27]. The ligation of PS
receptor has been proposed as the primary mechanism to
block the release of pro-inflammatory cytokine in vitro and
in vivo [11,15,16].
2.2. Other surface alterations and ligand expression on
apoptotic cells
Carbohydrate changes on the surface of apoptotic cells
may be important in triggering recognition as demonstrated
by studies of lectin-like receptors in a wide range of
phagocytes, both professional and semi-professional
[28,29]. The mannose receptor of Mf and liver endothelial
cells is the best-characterized member of a family of surface
lectin receptors that mediates binding and internalization of
mannose and fucose [28,29]. It has been suggested that the
asialoglycoprotein and the galactose-specific receptors of
healthy hepatocytes and sinusoidal liver cells are implicated
in the engulfment of apoptotic hepatocytes, likely in coop-
eration with other hepatic carbohydrate-specific receptor
systems [29].
The collectins are a family of complex proteins that
include surfactant-binding proteins A and D, the mannose-
binding lectin and the first component of the complement
cascade (C1q). The finding that C1q and mannose-binding
lectin participate in apoptotic cell clearance in vitro [30] and
in vivo [31,32] followed the initial observation that C1q
binds to blebs on the surface of apoptotic cells [33]. The
collectins coat apoptotic cells via their globular heads and
initiate uptake by interacting with phagocyte receptors
through their structurally homologous collagenous tail
groups [30]. This interaction requires the recognition of a
tail group of calreticulin [34]. However, calreticulin lacks a
transmembrane domain, therefore, it is likely that it asso-
ciates with a transmembrane receptor, CD91 [35].
ICAM-3, a highly glycosylated Ig-superfamily member,
constitutively expressed on leukocytes, undergoes a quali-
tative change during apoptosis which alters its receptor-
binding properties and provides a signal engulfment by Mf
[36]. Apoptosis, in fact, results in the exposure of a
carbohydrate group that could bind to CD14, a multifunc-
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saccharide (LPS) receptor [37].
2.3. Scavenger receptors
Clearance of apoptotic cells can also be mediated by
scavenger receptors (SR) including the class SR-A, SR-B1,
oxidized low-density lipoprotein receptor-1 and CD36 [38–
40]. CD36, one of the first Mf receptors to be implicated in
the recognition of apoptotic cells [39,41], was first charac-
terized in the context of lipoprotein metabolism, foam cell
formation and atherosclerosis [42]. The role of CD36 in
phagocytosis was demonstrated by studies using anti-CD36
antibody and by the observation that its ectopic expression
gives phagocytic ability to non-phagocytic cells [41,43].
The bridging molecule thrombospondin (TPS) binds apo-
ptotic PMNs and link them to CD36 and the phagocyte
vitronectin receptor [39]. CD36 has been identified as a
necessary cofactor in PS-mediated recognition of apoptotic
cells [44].
CD36 was shown to play a role in the clearance of
photoreceptor rod outer segment by retinal pigment epithe-
lium [45]. In addition, glial cells, the resident macrophages
in the central nervous system, express SR [46]. SR-A
mediates the binding and phagocytosis of apoptotic cells
that express PS by neonatal microglia [46] and SR-B seems
to participate in astrocyte clearance of apoptotic cells in vivo
[47].
Although its activities are well-defined in vitro, the
contributions of SR-A in vivo have been difficult to deter-
mine. It has been demonstrated that apoptotic thymocyte
clearance in SRA-deficient mice is apparently normal [48].
The ability of SR to mediate recognition of apoptotic
cells is widely distributed in phylogeny. The hemocytes of
Drosophila melanogaster remove cells undergoing apopto-
sis during embryogenesis, through a receptor called Cro-
quemort (Crq), a homologue of the mammalian CD36 [49].
2.4. CD31
Recent data provide evidence for the presence of a
repulsive signal between Mf and leukocytes. Under flow
conditions, it has been demonstrated that Mf extends
processes that palpate leukocytes and if a leukocyte is
viable, it rapidly detaches from Mf. However, apoptotic
leukocytes remain in contact and phagocytosis is the even-
tual consequence of such contact [50]. Brown et al. [50]
suggested that apoptosis switches the repulsive signals that
are received by leukocytes CD31 to adhesive signals.
Ligation of CD31 on viable leukocytes promotes their
detachment, whereas in dying cells the signaling through
CD31 is disrupted, so the cell is not repelled. It has been
proposed that prolonged attachment per se may be necessary
but not sufficient for phagocytosis and that engagement of
PS receptor is required for the complete ingestion of dying
cells [2].3. Signaling mechanisms in apoptotic cell uptake
Phagocytosis is triggered by the interaction of the par-
ticles to be internalized with specific receptors on the surface
of the phagocyte. These receptors include the Fc receptors of
immunoglobulins and the complement receptors that bind to
complement on opsonised particles. Fc receptor-mediated
phagocytosis occurs by a zippering process in which repeat-
ed interactions between ligands on the target particle and
receptors on the phagocyte cell are required until complete
internalization of the particle is achieved within a special-
ized structure, the phagosome [51–53]. In complement-
mediated phagocytosis, the particles sink into the phagocyte
with minimal membrane disturbance [13].
Uptake of apoptotic cells has been suggested to involve
two separate steps. Individual or multiple engagements of
many receptors including CD14, CD68, CD36 and avh3
integrin result in the binding of the particles that are not
ingested until PS is present [4]. Therefore, the engulfment of
apoptotic cells involves an initial tethering event followed
by a PSR-mediated uptake by a process akin to macro-
pinocytosis [54]. In macropinocytosis, local membrane
ruffling is associated with enclosure of extracellular fluid
followed by internalization in a so-called ‘‘tether and tickle’’
mechanism [54]. Adhesion ligands lead to attachment of the
apoptotic cell (tethering), but they are not able to trigger
uptake. Engagement of signaling receptors (the ‘tickle’
component) then leads to initiation of uptake signals pro-
viding more opportunities for regulation and specificity.
This mechanism requires Rac-1 and Cdc42, members of
the Rho family of GTPases [55].
The assembly and disassembly of peripheral actin fila-
ments is used to promote localized changes in the structure
of membranes during phagocytosis. Members of the
RhoGTPases (RhoA, Rac and Cdc42) regulate many signal
transduction pathways linking plasma membrane receptors
to the assembly of distinct filamentous actin structures [56].
Differential involvement of specific Rho family members
has been demonstrated in phagocytosis in response to
stimulation of Fc or complement receptors. Rac and
Cdc42 have been shown to regulate actin reorganization
during Fc receptor-mediated phagocytosis by promoting
pseudopod extension and phagosome closure [57–60],
whereas complement-mediated phagocytosis, a process not
associated with the release of pro-inflammatory molecules,
requires the activation of RhoA [58]. Phagocytosis of
apoptotic cells shares some of the characteristics of both
mechanisms. Similar to the Fc receptor-mediated phagocy-
tosis, internalization of the apoptotic cells is due to exten-
sion of the phagocyte membrane around the cell to be
engulfed [61] and require Rac and Cdc42, whereas inhibi-
tion of Rho enhanced phagocytosis [62]. Rac and Cdc42
may exert their action through the Wiskott–Aldrich syn-
drome protein (WASp). WASp is activated by Cdc42 to
stimulate actin polymerization through the Arp2/3 complex
[63].
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in recruitment of the p130cas CrkII–DOCK 180 molecular
complex which in turn triggers Rac 1 activation and
phagosome formation [64], a process analogous to the
homologous CED2–CED5–CED10–CED12 complex of
engulfment genes defined in the nematode Caenorhabditis
elegans [65–67]. In C. elegans apoptotic cells are engulfed
by non-professional, neighbouring cells. On the basis of
their genetic interactions, the engulfment genes fall into two
partially redundant sets, ced-1, ced-6, ced-7 on the one hand
and ced-2, ced-5, ced-10 and ced-12, on the other [68,69].
Candidate orthologs in mammals exist for all of these and
have been defined on the basis of the sequence or of the
functional conservation. Ced-1, ced-6 and ced-7 encode a
transmembrane protein similar to scavenger-receptor, a
protein-binding domain containing an adaptor protein and
an ABC transporter, respectively [70–72]. The ABC trans-
porter CED-7 promotes cell corpse recognition by CED-1,
possibly by exposing a phospholipid ligand on the surfaces
of cell corpses [70]. The distribution of CED-1 at the plasma
membrane of the engulfing cell and in particular in the
vicinity of the apoptotic target strongly suggest that it acts as
a receptor for some ligands in the recognition process [70].
Interestingly, in the nematode, a functional ced-7 gene is
required in both target and phagocytic cell for an effective
engulfment [72], a situation also observed for ABC1 in
mammalian cells [21].
CED-2, CED-5, CED-10, and CED-12 encode homo-
logues of mammalian CrkII, Dock180, Rac, and ELMO,
respectively, and function in phagocytic cells to transduce
another unknown cell corpse signal to the actin cytoskeleton
of the phagocytic cell [64,66,67,70]. In mammalian cells,
Ced12/ELMO1 functionally cooperate with CrkII and
DOCK 180 to function upstream of CED-10/Rac1, leading
to cytoskeletal rearrangement [67].4. Role of dendritic cells in phagocytosis
Uptake of apoptotic cells by the most potent antigen-
presenting cells, DCs, plays a significant role in the immune
responses. Immature DCs in peripheral tissue can take up
antigens and process them. DCs then migrate to secondary
lymphoid organs and become competent to present antigen
to T lymphocytes, thus initiating antigen-specific immune
responses [73]. Ingestion of certain necrotic cells is capable
of inducing DC maturation, while DCs that have ingested
apoptotic cells have a reduced capacity to stimulate T cells
[74,75]. However, such DCs are capable of responding to
strong external stimuli, to mature and present antigens
derived from the ingested apoptotic cells to T cells
[76,77]. The ingestion of apoptotic cells by immature DCs
can inhibit their maturation and antigen presentation with
suppression of the secretion of IL-12, which has autocrine
and/or paracrine effects on cell maturation [74,75]. Interest-
ingly, the ingestion of apoptotic cells by macrophagesgenerates an active anti-inflammatory response through
the production of TGF-h1 and other anti-inflammatory
molecules and down-regulates subsequent release of pro-
inflammatory cytokines [44]. Therefore, a controlled mech-
anism of DC maturation is necessary to regulate an auto-
immune response due to the generation of autoantigens [78].
The ability of DCs to trigger immune responses to antigens
expressed by ingested apoptotic cells, however may be a
useful mechanism in tumour therapy. DCs loaded with
apoptotic tumour cells initiate immune responses against
the antigens expressed by dying cells, making then an
attractive target for anti-neoplastic immunisation [79].5. Endogenous regulators of phagocytosis of apoptotic
cells
Given that recognition and engulfment of apoptotic cells
is an important process in the resolution of inflammation, a
positive regulation of the capacity of Mf for phagocytosis
of dying cells represents a potential therapeutic target in the
control of inflammatory disease. In recent years, the role of
endogenous anti-inflammatory mediators in the modulation
of phagocytosis of apoptotic cells has emerged.
5.1. Glucocorticoids
Glucocorticoids are powerful anti-inflammatory agents
that suppress many phlogistic responses including inflam-
matory cell recruitment and activation [80]. Pretreatment
with glucocorticoids results in an increased clearance by
Mf and renal mesangial cells of apoptotic leukocytes from
different lineages without promoting the release of pro-
inflammatory cytokines in vitro [81]. Long-term exposure
of monocytes to dexamethasone reprograms them to a more
phagocytic phenotype with changes in adhesion-dependent
reorganization of the Mf cytoskeletal elements coupled to
activation of Rac [82]. These steroid reprogrammed Mf
present a reduced tyrosine phosphorylation of the compo-
nents of adhesion contacts, paxillin and pyk2 proteins and
loss of expression of p130cas, a mediator of adhesion
signaling [82]. These data suggest that phagocytic clearance
of apoptotic leukocytes may be a further mechanism
through which glucocorticoids exert their anti-inflammatory
activities.
5.2. Lipoxins
Lipoxins (LXs) formed by leukocytes during cell–cell
interactions under a variety of conditions including inflam-
mation, represent a unique class of lipid mediators with
potent anti-inflammatory actions [83–86]. In a cytokine
primed milieu, aspirin acetylation of cyclooxygenase type
2 switches the catalytic activity of the enzyme to an R-
lipoxygenase which initiates the biosynthesis of the 15-
epimer lipoxins (aspirin-triggered lipoxins, ATL) which
Fig. 1. Electron micrograph of LX-stimulated Mf phagocytosis of
apoptotic PMN. Mf were treated with LXA4 (1 nM for 15 min) before
coincubation with aged PMN for 30 min. Cells were fixed with
glutaraldehyde, postfixed in 1% osmium tetroxide and embedded in Epon
using standard methods. Sections were stained with uranyl acetate and lead
citrate and examined in a JEOL 2000EX microscope.
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[87].
LXA4 and its stable analogues bind to a G protein-
coupled receptor (ALXR) [83,85] and inhibit recruitment
of PMNs in vitro and in vivo models of inflammation [88–Fig. 2. Fluorescence micrograph of LX-stimulated Mf phagocytosis of apoptotic
with aged PMN for 30 min. Cells were fixed with paraformaldehyde. Localizatio
stained with Hoechst 33258. Images were visualized by fluorescence microsco
pseudopodia has ingested an apoptotic PMN.95]. LX can directly modulate the cytokine composition in a
local inflammatory milieu thereby participating in a nega-
tive feedback loop opposing inflammatory cytokine-induced
cell activation [96,97]. It is noteworthy that the ALXR can
bind pleiotropic ligands including peptide agonists [98],
prion protein [99], serum amyloid A [100] and the gluco-
corticoid-inducible protein annexin-1 [101]. Intriguingly,
recent data have shown that annexin-1 exposure on the
surface of apoptotic cells facilitates phagocytic clearance on
colocalization with PS [102].
LXs are potent activators of monocytes, stimulating
their chemotaxis and adherence without causing degranu-
lation or release of reactive species [103,104]. We have
recently demonstrated that LXs and ATL promote another
important step in the resolution phase of inflammation,
namely non-phlogistic phagocytosis of apoptotic PMN by
human monocyte-derived Mf in vitro (Figs. 1 and 2)
[105]. LXs stimulate phagocytosis of exogenously admin-
istered excess apoptotic PMN in a murine model of
thioglycollate-induced peritonitis in vivo, suggesting that
LX rapidly promote the clearance of apoptotic leukocytes
within an inflammatory milieu [106]. This effect of LXs on
phagocytosis of apoptotic PMNs by Mf can be blocked by
antibodies to several macrophage surface proteins known
to contribute to the recognition of apoptotic leukocytes
such CD36, avh3 and CD11b/CD18. The non-phlogistic
LX-stimulated phagocytosis is mediated by protein kinase
C and PI-3-kinase and is associated with increased produc-
tion of TGF-1h [106] (Fig. 3). A modulatory role for
cAMP is suggested by the observation that LX-induced
phagocytosis is inhibited by a cell permeant cAMP ana-
logue and mimicked by a PKA inhibitor [105]. Interest-
ingly, these data suggest that LX-stimulated phagocytosisPMN. Mf were treated with LXA4 (1 nM for 15 min) before coincubation
n of actin was determined using Oregon Green phalloidin and nuclei were
py using a  100 oil objective. A Mf with a polarized shape and with
Fig. 3. Phagocyte recognition of apoptotic cells is coupled to the resolution of inflammation. Several receptors are implicated in the uptake of apoptotic cells by
phagocytes. These receptors interact with their ligands on the apoptotic cells either directly or via bridging proteins. The role, cooperation and redundancy
amongst these receptors are discussed in the text. The mechanisms that are involved in the LX recognition of apoptotic cells are indicated in red. Increased
production of TGF-h1 and PGE2 have been demonstrated in several models following phagocytosis of apoptotic cells, increased expression of such mediators
is associated with decreased production of prototypic pro-inflammatory mediators such as TNF-a and IL-8 as discussed in the text.
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dent of the PS receptor as it was not blocked by anti-PS
receptor antisera or by pre-treatment of Mf with h1,3
glucan [106]. These results suggest that LXs promote
phagocytosis of apoptotic PMN either by increasing the
avidity of avh3-CD36 for PMN ligands or by influencing
cytoskeletal events. Indeed, LXs induce significant changes
in the reorganization of actin in human monocytes and Mf
resulting in the promotion of cytoplasmic extensions and in
the formation of pseudopodia with a mechanism that is
dependent on monomeric GTPases RhoA and Rac [107].
Given the role of the Rho family in cell motility and
phagocytosis, it may be proposed that LX pretreatment of
Mf might prime them for chemotaxis [104] and phagocy-
tosis, contributing to the potential role of LXs in the
resolution of inflammation.
It is noteworthy that while this paper was in review,
evidence for a further lipid mediator involved in phagocy-
tosis of apoptotic cells was reported. Apoptotic cells were
demonstrated to release lysophosphatidylcholine which
stimulates chemotaxis of phagocytic Mf [108].6. Consequences of impaired phagocytic clearance
The modulation of phagocytic capacity for apoptotic cell
clearance represents a potential therapeutic target in the
control of inflammatory disease. In this regard, in vivo
models, in which a deficiency in the clearance of apoptotic
cells is present, are useful to study the consequences of
inadequate phagocytosis of dying cells [31,109]. Mounting
evidence highlights a prominent role for complement com-
ponents in the homeostatic modulation of phagocytosis of
apoptotic cells, in particular the observation that C1q binds
specifically to the surface blebs of apoptotic cells [33]. The
importance of C1q in vivo is demonstrated by the fact that
inherited deficiencies of classical pathway components,
particularly C1q and C4, are inextricably linked with
development of systemic lupus erythematosus (SLE)
[110]. Elucidation of the mechanisms of association be-
tween C1q and autoimmune disorders has been provided by
a study using mice with a deficiency in C1q. The mice
spontaneously developed anti-nuclear antibodies and dis-
played major immuno-complexes deposition in the renal
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renal damage [32]. In addition, a marked accumulation of
apoptotic bodies in C1q / mice was demonstrated. This
observation correlated with the proposal that apoptotic cells,
when not efficiently cleared, may represent a source of
autoantigens that drive the autoimmune response in SLE
[111]. In fact, Mf from patients with SLE has been shown
in vitro to exhibit a reduction in the phagocytic uptake of
apoptotic cells [112]. Studies by Taylor et al. [31] have
investigated the relative contribution of different comple-
ment proteins to the phagocytosis of apoptotic cells by both
inflammatory and resident murine Mf using novel in vivo
peritoneal models of apoptotic cell clearance. C1q- and C4-
deficient mice exhibited impaired clearance of apoptotic
Jurkat T cells. However, C1q-deficient animals exhibited a
more severe defect in inflammatory Mf phagocytosis of
apoptotic murine thymocytes than C4-deficient mice, indi-
cating hierarchical superiority of classical pathway comple-
ment proteins in the phagocytic clearance of apoptotic cells
[31]. Also C1q-deficient mice were the only complement-
deficient animals to exhibit a defect in the phagocytosis of
apoptotic cells by resident peritoneal Mf in vivo. This
highlights the prominent role of C1q in mediating effective
clearance of apoptotic cells in vivo in the absence of
inflammation and strengthens the observation that apoptotic
cells on their surface blebs express many of the autoantigens
of SLE [111].
As already discussed the complex Mer/Gas-6/PS is
involved in the interaction between apoptotic cells and
phagocytes [23]. The implication of Mer in phagocytosis
is emphasized by in vivo studies in which it has been
demonstrated that thymi from Mer kinase-deficient mice
upon stimulation with dexamethasone, showed a seven-fold
accumulation of remnant apoptotic cells compared to wild-
type controls [109]. The accumulation of apoptotic cells was
not due to increased apoptosis, but to defective clearance by
Mf and the systemic exposure to apoptotic thymocytes in
mice results in the transient production of autoantibodies
[109]. Interestingly, the mutation in Mer / mice renders
them blind and coincidentally human patients with retinitis
pigmentosa associated with lack of clearance have been
shown to contain mutations in the Mer gene [113]. These
studies indicate a role for the Mer receptor as immunor-
egulator probably due to its ability to down-regulate the
production of cytokines such as TNF-a [114].
Cystic fibrosis is a disease characterized by early, pro-
tracted inflammation that is associated with a massive influx
of inflammatory cells and release of intracellular protease in
the lung [115]. An increased number of apoptotic cells has
been demonstrated in the airways of patients with cystic
fibrosis and non-cystic fibrosis bronchiectasis [116]. It has
been speculated that the defective airway clearance of
apoptotic cells observed in these pathological conditions
may be due to elastase-mediated cleavage of PS receptor on
phagocytes that may precipitate an ongoing inflammation
condition and progressive airway damage [116]. Given thatLX-stimulated phagocytosis appears to be independent of
the PS receptor, this suggests a potential therapeutic role for
LX in cystic fibrosis lung disease.
SR-A is expressed on microglia in the CNS, raising the
possibility that it may be actively involved in the develop-
ment of some neuronal disease, in particular with the
etiology of neurodegeneration in Alzheimer disease
[46,117]. Prominent expression of SR-A has been shown
on reactive microglia surrounding amyloid plaques [118]
and microglial scavenger receptors may be novel targets for
therapeutic interventions in Alzheimer’s disease. Indeed the
ability of the LX receptor to interact with serum amyloid A
[100] suggests that it may have a role in phagocytic
clearance of amyloid protein, an important strategy in the
accumulation of extracellular amyloid, a key feature of
neurodegenerative disorders.
Evidence of the anti-inflammatory effects of apoptotic
leukocyte clearance in immune-complex mediated arthritis
(ICA) are provided from experiments in which injection of
apoptotic leukocytes before the induction of ICA were
shown to be protective as uptake of the instilled apoptotic
leukocytes by synovial lining macrophages significantly
reduced subsequent PMN chemotaxis into the joint [119].7. Conclusions
The uptake of apoptotic cells by professional phagocytes
such as Mf, immature DCs and brain microglial cells is an
important step in the resolution of inflammation. The in
vitro mechanisms underlying the phagocytosis of apoptotic
cells are well defined but more studies are necessary to
clarify the importance of apoptotic cell clearance in vivo. In
addition, more studies are needed to define a clear link
between impaired phagocytosis of apoptotic cells and the
pathogenesis of diseases. These studies will facilitate the
development of new therapeutic strategies for autoimmune
and inflammatory diseases.Acknowledgements
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